Emerald Health Therapeutics, Inc(TSXV: EMH)
- Symbol:TSXV: EMH
- Ticker 2:OTCQX: EMHTF
- CEO:Riaz Bandali
Emerald Health Therapeutics, Inc (TSXV: EMH) Stock Price
Disclaimer: Past performance is not an indicator of future performance.
Emerald Health Therapeutics, Inc(TSXV: EMH) Company Overview
Emerald Health Therapeutics, Inc is a wholly-owned licensed producer of medical cannabis that focuses on "harnessing the complexity of the endocannabinoid system and the cannabis plant to create better-controlled outcomes for everyone."
Operating out of Canada, Emerald Health extracts, produces and markets pharmaceutical-grade medical cannabis, cannabis oils and capsules produces to roughly 97% of the addressable market.
Emerald Health operates 3 facilities in British Columbia, including a 1.1 million square foot greenhouse. The Company also runs an indoor cannabis production facility in Québec.
The Company recently announced a $2.1 Million prospectus sale, entering into a binding term sheet with a single Canadian institutional accredited investor for the purchase of 11,351,351 units of Emerald at a price of $0.185.